Streetbeat News

Price Targets

INCY

RBC Capital analyst Brian Abrahams has maintained a 'Sector Perform' rating on Incyte (NASDAQ:INCY) but lowered the price target from $74 to $63.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:35 pm

TREE

Susquehanna analyst James Friedman maintains a Neutral rating on LendingTree (NASDAQ:TREE) and lowers the price target from $23 to $15.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:27 pm

RIG

Susquehanna analyst Charles Minervino has maintained a Neutral rating on Transocean (NYSE:RIG) and lowered the price target from $9 to $7.5.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:26 pm

JBLU

Susquehanna analyst Christopher Stathoulopoulos has maintained a Neutral rating on JetBlue Airways (NASDAQ:JBLU) and lowered the price target from $5 to $4.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:25 pm

ETN

RBC Capital analyst Deane Dray has maintained a 'Sector Perform' rating on Eaton Corp (NYSE:ETN) and raised the price target from $215 to $220.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:24 pm

GPN

Susquehanna analyst James Friedman maintains a positive outlook on Global Payments (NYSE:GPN), but has lowered the price target from $180 to $150.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:24 pm

FWRD

Susquehanna analyst Bascome Majors maintains a positive outlook on Forward Air (NASDAQ:FWRD), but has lowered the price target from $84 to $75.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:22 pm

CSR

RBC Capital analyst Brad Heffern has maintained a 'Sector Perform' rating on Centerspace (NYSE:CSR) but lowered the price target from $60 to $58.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:21 pm

AEIS

Susquehanna analyst Mehdi Hosseini has maintained a Neutral rating on Advanced Energy Indus (NASDAQ:AEIS) and lowered the price target from $110 to $95.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:17 pm

TECH

RBC Capital analyst Conor McNamara has maintained a 'Sector Perform' rating on Bio-Techne (NASDAQ:TECH) and lowered the price target from $85 to $83.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:16 pm